Unichem Laboratories
UNICHEMLABNSE

Unichem Laboratories

₹284.05-14.65 (4.90%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
282.00
Today’s high
299.00
52 week low
296.10
52 week high
722.35
Open price
299.00
Previous close
298.70
Live volume
46,172
Lower circuit
239.00
Upper circuit
358.40

Fundamentals

Market Cap
₹2,105Cr
ROE
5.98%
P/E Ratio(TTM)
7.14
EPS(TTM)
41.89
P/B Ratio
0.86
Dividend Yield
0.00%
Industry P/E
32.08
Book Value
345.83
Debt to Equity
0.21
Face Value
2

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Unichem Laboratories is a global pharmaceutical company that manufactures Active Pharmaceutical Ingredients (APIs) and a wide range of finished drug formulations for international markets. It is driven by a commitment to quality and excellence, aiming to surpass stringent global manufacturing standards required for business in regulated markets. Demonstrating significant operational growth, its formulation output increased by 52%, reaching 15.17 billion tablets and capsules in the financial year 2025.;
MD/CEO
Mr. Pabitrakumar Bhattacharyya
Founded in
--
NSE symbol
UNICHEMLAB
Industry

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Promoters
70.22%
Retail And Others
18.05%
Mutual Funds
9.17%
Other Domestic Institutions
1.57%
Foreign Institutions
0.99%

Mutual Funds Invested (2)

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹671.35
-40.20 (5.65%)
L
    H
    4,080.1430.814
    ₹386.15
    -18.40 (4.55%)
    L
      H
      3,779.3342.175.18
      Aarti DrugsAARTIDRUGS
      ₹330.70
      -10.40 (3.05%)
      L
        H
        3,110.0315.362.12
        ₹251.80
        -16.35 (6.10%)
        L
          H
          2,927.3561.211.07
          Livesquawk
          Unichem Labs' Q3 revenue stands at 5.2B rupees, down from 5.33B YoY.
          Livesquawk
          Unichem Labs' Kolhapur facility inspected by USFDA, resulting in 5 observations. No data integrity issues were found during the USFDA inspection.
          Livesquawk
          Unichem Lab posted Q2 net loss of ₹119M vs profit of ₹246M YOY. The company's Q2 revenue rose to ₹5.79B from ₹5.07B YOY.
          2026
          5
          Feb
          Quarterly Result
          Release date
          2025
          11
          Nov
          Quarterly Result
          Release date
          4
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks